These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells. Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460 [TBL] [Abstract][Full Text] [Related]
5. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. Li H; Han Y; Guo Q; Zhang M; Cao X J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155 [TBL] [Abstract][Full Text] [Related]
6. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314 [TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors. Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342 [TBL] [Abstract][Full Text] [Related]
8. Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Burga RA; Thorn M; Point GR; Guha P; Nguyen CT; Licata LA; DeMatteo RP; Ayala A; Joseph Espat N; Junghans RP; Katz SC Cancer Immunol Immunother; 2015 Jul; 64(7):817-29. PubMed ID: 25850344 [TBL] [Abstract][Full Text] [Related]
9. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. Kong X; Sun R; Chen Y; Wei H; Tian Z J Immunol; 2014 Aug; 193(4):1645-53. PubMed ID: 25015833 [TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells. Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression. Tsukamoto H; Nishikata R; Senju S; Nishimura Y Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249 [TBL] [Abstract][Full Text] [Related]
13. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model. Huang X; Cui S; Shu Y Immunol Res; 2016 Feb; 64(1):160-70. PubMed ID: 26590944 [TBL] [Abstract][Full Text] [Related]
15. MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation. Yaddanapudi K; Rendon BE; Lamont G; Kim EJ; Al Rayyan N; Richie J; Albeituni S; Waigel S; Wise A; Mitchell RA Cancer Immunol Res; 2016 Feb; 4(2):101-12. PubMed ID: 26603621 [TBL] [Abstract][Full Text] [Related]
16. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103 [TBL] [Abstract][Full Text] [Related]
17. Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells. Michel A; Schüler A; Friedrich P; Döner F; Bopp T; Radsak M; Hoffmann M; Relle M; Distler U; Kuharev J; Tenzer S; Feyerabend TB; Rodewald HR; Schild H; Schmitt E; Becker M; Stassen M J Immunol; 2013 Jun; 190(11):5534-44. PubMed ID: 23636054 [TBL] [Abstract][Full Text] [Related]
18. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002 [TBL] [Abstract][Full Text] [Related]
19. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210. Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559 [TBL] [Abstract][Full Text] [Related]
20. The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis. Vrakas CN; O'Sullivan RM; Evans SE; Ingram DA; Jones CB; Phuong T; Kurt RA Immunol Invest; 2015; 44(2):174-88. PubMed ID: 25255046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]